annual EBIT:
$2.94M+$457.35M(+100.65%)Summary
- As of today (June 22, 2025), BPMC annual earnings before interest & taxes is $2.94 million, with the most recent change of +$457.35 million (+100.65%) on December 31, 2024.
- During the last 3 years, BPMC annual EBIT has risen by +$637.12 million (+100.46%).
- BPMC annual EBIT is now -99.05% below its all-time high of $308.71 million, reached on December 31, 2020.
Performance
BPMC EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
$19.09M+$50.21M(+161.35%)Summary
- As of today (June 22, 2025), BPMC quarterly earnings before interest & taxes is $19.09 million, with the most recent change of +$50.21 million (+161.35%) on March 31, 2025.
- Over the past year, BPMC quarterly EBIT has dropped by -$85.30 million (-81.71%).
- BPMC quarterly EBIT is now -96.99% below its all-time high of $633.37 million, reached on September 30, 2020.
Performance
BPMC quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$82.35M-$85.30M(-2897.35%)Summary
- As of today (June 22, 2025), BPMC TTM earnings before interest & taxes is -$82.35 million, with the most recent change of -$85.30 million (-2897.35%) on March 31, 2025.
- Over the past year, BPMC TTM EBIT has increased by +$150.35 million (+64.61%).
- BPMC TTM EBIT is now -124.32% below its all-time high of $338.65 million, reached on June 30, 2021.
Performance
BPMC TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
BPMC EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +100.7% | -81.7% | +64.6% |
| 3 y3 years | +100.5% | +118.6% | +87.1% |
| 5 y5 years | +100.8% | +116.8% | +78.6% |
BPMC EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +100.5% | -81.7% | +112.2% | -2897.3% | +88.1% |
| 5 y | 5-year | -99.0% | +100.5% | -97.0% | +106.1% | -124.3% | +88.1% |
| alltime | all time | -99.0% | +100.5% | -97.0% | +106.1% | -124.3% | +88.1% |
BPMC EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $19.09M(-161.4%) | -$82.35M(-2897.4%) |
| Dec 2024 | $2.94M(-100.6%) | -$31.12M(-16.4%) | $2.94M(-104.8%) |
| Sep 2024 | - | -$37.24M(+12.5%) | -$61.79M(-57.4%) |
| Jun 2024 | - | -$33.09M(-131.7%) | -$144.93M(-37.7%) |
| Mar 2024 | - | $104.39M(-208.9%) | -$232.70M(-48.8%) |
| Dec 2023 | -$454.41M(-14.0%) | -$95.85M(-20.4%) | -$454.41M(-9.8%) |
| Sep 2023 | - | -$120.38M(-0.4%) | -$503.81M(-0.1%) |
| Jun 2023 | - | -$120.86M(+3.0%) | -$504.36M(-6.6%) |
| Mar 2023 | - | -$117.32M(-19.2%) | -$540.08M(+2.8%) |
| Dec 2022 | -$528.57M(-16.7%) | -$145.25M(+20.1%) | -$525.29M(-24.1%) |
| Sep 2022 | - | -$120.93M(-22.8%) | -$691.65M(+1.0%) |
| Jun 2022 | - | -$156.57M(+52.7%) | -$684.54M(+7.6%) |
| Mar 2022 | - | -$102.54M(-67.1%) | -$636.48M(+0.4%) |
| Dec 2021 | -$634.18M(-305.4%) | -$311.60M(+173.8%) | -$634.18M(+55.2%) |
| Sep 2021 | - | -$113.83M(+4.9%) | -$408.54M(-220.6%) |
| Jun 2021 | - | -$108.51M(+8.3%) | $338.65M(+5.1%) |
| Mar 2021 | - | -$100.24M(+16.6%) | $322.13M(+4.3%) |
| Dec 2020 | $308.71M(-185.4%) | -$85.97M(-113.6%) | $308.71M(-5.1%) |
| Sep 2020 | - | $633.37M(-606.5%) | $325.29M(-180.1%) |
| Jun 2020 | - | -$125.04M(+10.0%) | -$406.03M(+5.5%) |
| Mar 2020 | - | -$113.66M(+63.8%) | -$384.91M(+6.5%) |
| Dec 2019 | -$361.33M | -$69.38M(-29.2%) | -$361.33M(-5.6%) |
| Sep 2019 | - | -$97.96M(-5.7%) | -$382.73M(+7.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$103.91M(+15.4%) | -$357.47M(+27.4%) |
| Mar 2019 | - | -$90.07M(-0.8%) | -$280.58M(+13.6%) |
| Dec 2018 | -$247.03M(+63.3%) | -$90.78M(+24.8%) | -$247.03M(+18.4%) |
| Sep 2018 | - | -$72.71M(+169.0%) | -$208.58M(+20.2%) |
| Jun 2018 | - | -$27.02M(-52.2%) | -$173.53M(-3.5%) |
| Mar 2018 | - | -$56.52M(+8.0%) | -$179.86M(+18.9%) |
| Dec 2017 | -$151.25M(+110.0%) | -$52.33M(+39.0%) | -$151.25M(+25.9%) |
| Sep 2017 | - | -$37.66M(+12.9%) | -$120.09M(+21.1%) |
| Jun 2017 | - | -$33.35M(+19.5%) | -$99.16M(+17.3%) |
| Mar 2017 | - | -$27.91M(+31.8%) | -$84.57M(+17.4%) |
| Dec 2016 | -$72.03M(+38.3%) | -$21.17M(+26.6%) | -$72.03M(+8.7%) |
| Sep 2016 | - | -$16.73M(-10.9%) | -$66.27M(+6.9%) |
| Jun 2016 | - | -$18.77M(+22.1%) | -$62.01M(+10.6%) |
| Mar 2016 | - | -$15.36M(-0.3%) | -$56.05M(+7.6%) |
| Dec 2015 | -$52.07M(+30.7%) | -$15.41M(+23.6%) | -$52.07M(+2.2%) |
| Sep 2015 | - | -$12.47M(-2.6%) | -$50.98M(+4.3%) |
| Jun 2015 | - | -$12.80M(+12.4%) | -$48.89M(+10.4%) |
| Mar 2015 | - | -$11.39M(-20.5%) | -$44.28M(+11.2%) |
| Dec 2014 | -$39.83M(+91.7%) | -$14.32M(+37.9%) | -$39.83M(+56.1%) |
| Sep 2014 | - | -$10.38M(+26.7%) | -$25.52M(+68.6%) |
| Jun 2014 | - | -$8.20M(+18.2%) | -$15.13M(+118.2%) |
| Mar 2014 | - | -$6.93M | -$6.93M |
| Dec 2013 | -$20.77M | - | - |
FAQ
- What is Blueprint Medicines annual earnings before interest & taxes?
- What is the all time high annual EBIT for Blueprint Medicines?
- What is Blueprint Medicines annual EBIT year-on-year change?
- What is Blueprint Medicines quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Blueprint Medicines?
- What is Blueprint Medicines quarterly EBIT year-on-year change?
- What is Blueprint Medicines TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Blueprint Medicines?
- What is Blueprint Medicines TTM EBIT year-on-year change?
What is Blueprint Medicines annual earnings before interest & taxes?
The current annual EBIT of BPMC is $2.94M
What is the all time high annual EBIT for Blueprint Medicines?
Blueprint Medicines all-time high annual earnings before interest & taxes is $308.71M
What is Blueprint Medicines annual EBIT year-on-year change?
Over the past year, BPMC annual earnings before interest & taxes has changed by +$457.35M (+100.65%)
What is Blueprint Medicines quarterly earnings before interest & taxes?
The current quarterly EBIT of BPMC is $19.09M
What is the all time high quarterly EBIT for Blueprint Medicines?
Blueprint Medicines all-time high quarterly earnings before interest & taxes is $633.37M
What is Blueprint Medicines quarterly EBIT year-on-year change?
Over the past year, BPMC quarterly earnings before interest & taxes has changed by -$85.30M (-81.71%)
What is Blueprint Medicines TTM earnings before interest & taxes?
The current TTM EBIT of BPMC is -$82.35M
What is the all time high TTM EBIT for Blueprint Medicines?
Blueprint Medicines all-time high TTM earnings before interest & taxes is $338.65M
What is Blueprint Medicines TTM EBIT year-on-year change?
Over the past year, BPMC TTM earnings before interest & taxes has changed by +$150.35M (+64.61%)